 Shares of Progyny Inc. PGNY, 0.17 gained 0.4 in premarket trading Monday, after the fertility benefits management company raised is fourth-quarter financial outlook, given the surprising resumption of deliveries fertility drug Menopur. The company raised its guidance ranges for fourth-quarter earnings per share to 2 cents to 3 cents from a per-share loss of 1 cents to EPS of 2 cents, and for revenue to 208.9 million to 213.9 million from 202.4 million to 212.4 million. 